Search research articles
Contact Us
Filters
Showing results (61-70 of 99) with videos related to
Page
of 10
Sort By:
British Journal of Haematology
|
April 14, 2006
Use of the oral chelator deferiprone in the treatment of iron overload in patients with Hb H disease
Joyce C W Chan, Chor-Sang Chim, Clara G C Ooi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 29, 2014
11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT
Chi-lai Ho, Sirong Chen, Yim Lung Leung, et al.
Cancer Cell International
|
August 29, 2020
Epigenetic silencing of long non-coding RNA <i>BM742401</i> in multiple myeloma: impact on prognosis and myeloma dissemination
Zhenhai Li, Shaji Kumar, Dong-Yan Jin, et al.
Blood
|
August 25, 2012
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
Yok-Lam Kwong, Won Seog Kim, Soon Thye Lim, et al.
Blood
|
August 23, 2003
Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
Chor-Sang Chim, Shing-Yan Ma, Wing-Yan Au, et al.
Journal of Translational Medicine
|
February 25, 2014
Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia
Lu Qian Wang, Yok Lam Kwong, Kit Fai Wong, et al.
Molecular Cancer
|
December 31, 2013
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway
Lu Qian Wang, Yok Lam Kwong, Chi Shan Bonnie Kho, et al.
British Journal of Haematology
|
December 15, 2005
Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide
Wing-Yan Au, Alvin T Fung, Edmond S Ma, et al.
The Lancet. Oncology
|
November 2, 2013
Management of multiple myeloma in Asia: resource-stratified guidelines
Daryl Tan, Wee Joo Chng, Takaaki Chou, et al.
Hematological Oncology
|
August 14, 2020
Low-dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource-constrained setting
Thomas S Y Chan, Yu-Yan Hwang, Pek-Lan Khong, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 99) with videos related to
Sort By:
Page
of 10
British Journal of Haematology
|
April 14, 2006
Use of the oral chelator deferiprone in the treatment of iron overload in patients with Hb H disease
Joyce C W Chan, Chor-Sang Chim, Clara G C Ooi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 29, 2014
11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT
Chi-lai Ho, Sirong Chen, Yim Lung Leung, et al.
Cancer Cell International
|
August 29, 2020
Epigenetic silencing of long non-coding RNA <i>BM742401</i> in multiple myeloma: impact on prognosis and myeloma dissemination
Zhenhai Li, Shaji Kumar, Dong-Yan Jin, et al.
Blood
|
August 25, 2012
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
Yok-Lam Kwong, Won Seog Kim, Soon Thye Lim, et al.
Blood
|
August 23, 2003
Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
Chor-Sang Chim, Shing-Yan Ma, Wing-Yan Au, et al.
Journal of Translational Medicine
|
February 25, 2014
Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia
Lu Qian Wang, Yok Lam Kwong, Kit Fai Wong, et al.
Molecular Cancer
|
December 31, 2013
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway
Lu Qian Wang, Yok Lam Kwong, Chi Shan Bonnie Kho, et al.
British Journal of Haematology
|
December 15, 2005
Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide
Wing-Yan Au, Alvin T Fung, Edmond S Ma, et al.
The Lancet. Oncology
|
November 2, 2013
Management of multiple myeloma in Asia: resource-stratified guidelines
Daryl Tan, Wee Joo Chng, Takaaki Chou, et al.
Hematological Oncology
|
August 14, 2020
Low-dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource-constrained setting
Thomas S Y Chan, Yu-Yan Hwang, Pek-Lan Khong, et al.
Page
of 10